{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:13:37Z","timestamp":1785208417444,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["N-115924"],"award-info":[{"award-number":["N-115924"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["N-115924"],"award-info":[{"award-number":["N-115924"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["N-115924"],"award-info":[{"award-number":["N-115924"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.talanta.2021.122883","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:12:18Z","timestamp":1631671938000},"page":"122883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and validation of a targeted LC-MS\/MS quantitation method to monitor cell culture expression of tetanus neurotoxin during vaccine production"],"prefix":"10.1016","volume":"236","author":[{"given":"Antoine","family":"Francotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-4725","authenticated-orcid":false,"given":"Raphael","family":"Esson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Abachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Vanhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Dobly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Carpick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Uhlrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2291-8635","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Dierick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-3706","authenticated-orcid":false,"given":"Celine","family":"Vanhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2021.122883_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.15252\/embr.201744198","article-title":"The structure of the tetanus toxin reveals pH-mediated domain dynamics","volume":"18","author":"Masuyer","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.talanta.2021.122883_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.talanta.2021.122883_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2021.122883_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","article-title":"Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus","volume":"710","author":"Schiavo","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.talanta.2021.122883_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.15585\/mmwr.mm6917a2","article-title":"Progress toward maternal and neonatal tetanus elimination - worldwide, 2000-2018","volume":"69","author":"Njuguna","year":"2020","journal-title":"MMWR, Morbidity and mortality weekly report"},{"key":"10.1016\/j.talanta.2021.122883_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/cei.12822","article-title":"Adult vaccination against tetanus and diphtheria: the European perspective","volume":"187","author":"Weinberger","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.talanta.2021.122883_bib8","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1002\/jps.21261","article-title":"Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability","volume":"97","author":"Salnikova","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.talanta.2021.122883_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biologicals.2020.02.001","article-title":"A next-generation sequencing based method for determining genetic stability in Clostridium tetani vaccine strains","volume":"64","author":"Pennings","year":"2020","journal-title":"Biologicals: J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.talanta.2021.122883_bib10","first-page":"73","article-title":"The consistency approach for the quality control of vaccines, Biologicals","volume":"36","author":"Hendriksen","year":"2008","journal-title":"J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.talanta.2021.122883_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.anaerobe.2016.07.006","article-title":"Tetanus toxin production is triggered by the transition from amino acid consumption to peptides","volume":"41","author":"Licona-Cassani","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.talanta.2021.122883_bib12","first-page":"661","article-title":"Flocculation dans un m\u00e9lange neuter de toxine-antitoxine dipht\u00e9riques","volume":"86","author":"Ramon","year":"1922","journal-title":"Comptes Rendus Seances Soc. Biol. Ses Fil."},{"key":"10.1016\/j.talanta.2021.122883_bib13","first-page":"711","article-title":"Sur une technique de titration in vitro du serum antidipht\u00e9rique","volume":"86","author":"Ramon","year":"1922","journal-title":"Comptes Rendus Seances Soc. Biol. Ses Fil."},{"key":"10.1016\/j.talanta.2021.122883_bib14","first-page":"813","article-title":"A propos du titrage in vitro du serum antidipht\u00e9rique par la flocculation","volume":"86","author":"Ramon","year":"1922","journal-title":"Comptes Rendus Seances Soc. Biol. Ses Fil."},{"key":"10.1016\/j.talanta.2021.122883_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-1157(87)90014-X","article-title":"The quantitative estimation of diphtheria and tetanus toxoids. 1. The flocculation test and the Lf unit","volume":"15","author":"Lyng","year":"1987","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.talanta.2021.122883_bib16","first-page":"365","article-title":"Estimation of tetanus toxoid by different methods, including haemagglutination inhibition","volume":"1","author":"Fulthorpe","year":"1958","journal-title":"Immunology"},{"key":"10.1016\/j.talanta.2021.122883_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7883\/yoken1952.23.117","article-title":"Variation of Lf value of tetanus toxin depending on the reference antitoxins for flocculation","volume":"23","author":"Yamamoto","year":"1970","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.talanta.2021.122883_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/abio.2001.5496","article-title":"Characterization of tetanus toxin, neat and in culture supernatant, by electrospray mass spectrometry","volume":"301","author":"van Baar","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2021.122883_bib19","first-page":"478","article-title":"Immunofermentnoe opredelenie stolbniachnogo toksina i anatoksina s ispol'zovaniem monoklonal'nykh antitel [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies]","volume":"40","author":"Sviridov","year":"2004","journal-title":"Prikladnaia biokhimiia i mikrobiologiia"},{"key":"10.1016\/j.talanta.2021.122883_bib20","first-page":"466","article-title":"In vitro antigen ELISA for quality control of tetanus vaccines, Biologicals","volume":"40","author":"Coombes","year":"2012","journal-title":"J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.talanta.2021.122883_bib21","first-page":"8","article-title":"Evaluation of a capture antigen ELISA for the characterisation of tetanus vaccines for veterinary use, Biologicals","volume":"61","author":"Riches-Duit","year":"2019","journal-title":"J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.talanta.2021.122883_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/toxins12050328","article-title":"Tetanus toxin synthesis is under the control of A complex network of regulatory genes in Clostridium tetani","volume":"12","author":"Chapeton-Montes","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.talanta.2021.122883_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jobm.3620310212","article-title":"A solid-phase enzyme immunoassay for the detection of tetanus toxin using human and murine monoclonal antibodies","volume":"31","author":"Kiessig","year":"1991","journal-title":"J. Basic Microbiol."},{"key":"10.1016\/j.talanta.2021.122883_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/iai.43.2.710-714.1984","article-title":"Production and characterization of monoclonal antibodies to tetanus toxin","volume":"43","author":"Sheppard","year":"1984","journal-title":"Infect. Immun."},{"key":"10.1016\/j.talanta.2021.122883_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02124513","article-title":"Monoclonal antibodies against tetanus toxin and toxoid","volume":"172","author":"Ahnert-Hilger","year":"1983","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.talanta.2021.122883_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/mas.21571","article-title":"The expanding role of mass spectrometry in the field of vaccine development","volume":"39","author":"Sharma","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.talanta.2021.122883_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpba.2019.02.029","article-title":"Quantitative determination of bioactive proteins in diphtheria tetanus acellular pertussis (DTaP) vaccine by liquid chromatography tandem mass spectrometry","volume":"169","author":"Long","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2021.122883_bib28","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1128\/AEM.71.9.5604-5606.2005","article-title":"Molecular characterization of Clostridium tetani strains by pulse-field gel electrophoresis and colony PCR","volume":"71","author":"Plourde-Owobi","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.talanta.2021.122883_bib29","series-title":"Monograph 2.7.27: Flocculation Value (Lf) of Diphtheria and Tetanus Toxins and Toxoids","year":"2020"},{"key":"10.1016\/j.talanta.2021.122883_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.talanta.2021.122883_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1373\/clinchem.2015.250563","article-title":"Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays","volume":"62","author":"Hoofnagle","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib32","series-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH, Q2(R1) - Validation of Analytical Procedures: Text and Methodology","year":"1994"},{"key":"10.1016\/j.talanta.2021.122883_bib33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11095-007-9242-3","article-title":"A total error approach for the validation of quantitative analytical methods","volume":"24","author":"Hoffman","year":"2007","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.talanta.2021.122883_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpba.2007.06.013","article-title":"Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II","volume":"45","author":"Hubert","year":"2007","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2021.122883_bib35","series-title":"The Statistical Analysis of Experimental Data","author":"Mandel","year":"1964"},{"key":"10.1016\/j.talanta.2021.122883_bib36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.talanta.2017.06.034","article-title":"Analysis of illegal peptide drugs via HILIC-DAD-MS","volume":"174","author":"Janvier","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2021.122883_bib37","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1016\/j.chroma.2011.07.029","article-title":"Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines","volume":"1218","author":"Sacr\u00e9","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2021.122883_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.talanta.2015.04.022","article-title":"Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies","volume":"142","author":"Vanhee","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2021.122883_bib39","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00216-018-0848-6","article-title":"Development of an LC-MS\/MS peptide mapping protocol for the NISTmAb","volume":"410","author":"Mouchahoir","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib40","unstructured":"M. Faria, M. S. Halquist, Internal standards for absolute quantification of large molecules (proteins) from biological matrices by LC-MS\/MS, in Calibration and Validation of Analytical Methods, A Sampling of Current Approaches, https\/\/\/doi.org\/10.5772\/intechopen.75569."},{"key":"10.1016\/j.talanta.2021.122883_bib41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jprot.2013.11.004","article-title":"Isotope dilution mass spectrometry for absolute quantification in proteomics: concepts and strategies","volume":"96","author":"Villanueva","year":"2014","journal-title":"J. Proteo."},{"key":"10.1016\/j.talanta.2021.122883_bib42","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1021\/acs.analchem.8b04581","article-title":"MacCoss, calibration using a single-point external reference material harmonizes quantitative mass spectrometry proteomics data between platforms and laboratories","volume":"90","author":"Pino","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1373\/clinchem.2015.245266","article-title":"First steps toward harmonization of LC-MS\/MS thyroglobulin assays","volume":"62","author":"Netzel","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib44","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1373\/clinchem.2008.115543","article-title":"Quantification of urinary albumin by using protein cleavage and LC-MS\/MS","volume":"55","author":"Seegmiller","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1021\/acs.jproteome.7b00660","article-title":"Comparison of internal standard approaches for SRM analysis of alpha-synuclein in cerebrospinal fluid","volume":"17","author":"Oeckl","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.talanta.2021.122883_bib46","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/ac5001477","article-title":"Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein","volume":"86","author":"Nouri-Nigjeh","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2021.122883_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/dta.2029","article-title":"Identification of epidermal growth factor (EGF), in an unknown pharmaceutical preparation suspected to contain insulin like growth factor 1 (IGF-1)","volume":"9","author":"Vanhee","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.talanta.2021.122883_bib48","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jprot.2009.03.007","article-title":"Isotope dilution strategies for absolute quantitative proteomics","volume":"72","author":"Brun","year":"2009","journal-title":"J. Proteo."},{"key":"10.1016\/j.talanta.2021.122883_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4155\/bio-2019-0032","article-title":"Protein quantification by LC\u2013MS: a decade of progress through the pages of Bioanalysis","volume":"11","author":"van de Merbel","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2021.122883_bib50","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH, Harmonised Guideline Bioanalytical Method Validation M10."},{"key":"10.1016\/j.talanta.2021.122883_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/am.16.1.69-72.1968","article-title":"Continuous production of Clostridium tetani toxin","volume":"16","author":"Zacharias","year":"1968","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.talanta.2021.122883_bib52","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10295-020-02330-3","article-title":"Time-course transcriptomics reveals that amino acids catabolism plays a key role in toxinogenesis and morphology in Clostridium tetani","volume":"47","author":"Orellana","year":"2020","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.talanta.2021.122883_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/proteomes7020015","article-title":"More than a toxin: protein inventory of Clostridium tetani toxoid vaccines","volume":"7","author":"M\u00f6ller","year":"2019","journal-title":"Proteomes"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914021008043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914021008043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:00:51Z","timestamp":1758546051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914021008043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"alternative-id":["S0039914021008043"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122883","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a targeted LC-MS\/MS quantitation method to monitor cell culture expression of tetanus neurotoxin during vaccine production","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122883"}}